Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $20.2600 (0.9%) ($19.9100 - $20.3200) on Tue. Dec. 26, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.67% (three month average) | RSI | 75 | Latest Price | $20.2600(0.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.6% a day on average for past five trading days. | Weekly Trend | HALO advances 2.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(57%) IWO(56%) XBI(54%) IWM(51%) ARKG(50%) | Factors Impacting HALO price | HALO will decline at least -1.335% in a week (0% probabilities). VIXM(-12%) UUP(-12%) TLT(-6%) SHY(-4%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.335% (StdDev 2.67%) | Hourly BBV | 0 () | Intraday Trend | 0.9% | | | |
|
5 Day Moving Average | $19.98(1.4%) | 10 Day Moving Average | $20.02(1.2%) | 20 Day Moving Average | $19.39(4.49%) | To recent high | -2.6% | To recent low | 22.3% | Market Cap | $2.769b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |